Another compound, Pimozide, an antipsychotic agent, was recently suggested as a potential AD therapeutic which was reported to reduce toxic forms of tau protein by enhanced autophagy activity via AMPK-ULK1 axis stimulation [62]. Here, ULK1 is linked to Alzheimer disease.